Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
58.10
+0.70 (1.22%)
Oct 28, 2026, 4:00 PM EDT

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
27,02626,56417,23719,53016,03014,959
Market Cap Growth
-4.22%54.11%-11.74%21.83%7.16%-
Enterprise Value
26,64425,70417,34218,89114,51814,805
Last Close Price
58.1057.6041.4747.8539.3737.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.9033.1647.89213.94-1454.37
PB Ratio
23.9420.5086.1623.019.126.07
P/TBV Ratio
36.0329.60-50.5112.667.53

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
27.5032.0848.18206.94-1439.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.200.965.790.480.050.04
Net Debt / Equity Ratio
-0.34-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
0.630.90-0.340.301.773.12
Net Debt / FCF Ratio
0.540.92-0.400.341.973.97
Asset Turnover
0.320.340.220.05-0.01
Inventory Turnover
0.950.840.280.54--
Quick Ratio
2.492.111.111.785.709.82
Current Ratio
2.632.221.272.035.939.96
Return on Equity (ROE)
-43.70%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
-13.68%-21.71%-37.81%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
-32.20%-40.60%-104.20%-110.20%-43.20%-26.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.22%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
-2.60%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-9.39%-7.75%-1.83%-0.70%-12.29%-0.07%